Marshall Wace, LLP Edwards Lifesciences Corp Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 6,895,579 shares of EW stock, worth $530 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
6,895,579
Previous 3,030,671
127.53%
Holding current value
$530 Million
Previous $220 Million
145.51%
% of portfolio
0.66%
Previous 0.3%
Shares
31 transactions
Others Institutions Holding EW
# of Institutions
1,438Shares Held
484MCall Options Held
2.93MPut Options Held
1.57M-
Vanguard Group Inc Valley Forge, PA70MShares$5.38 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.92 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$1.97 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.69 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA19.8MShares$1.53 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $47.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...